Randomised phase 3B study on comparison of 2 treatment schedules with peginterferon alpha 2b and ribavirin short term versus standard term schedules in patients with chronic hepatitis C, genotype 2 or 3 and early virologic response comparison of efficacy, tolerability, quality of life and costs.
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 Aug 2011 New trial record